ANTX financials

AN2 Therapeutics (ANTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

ANTX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$38.11M-$35.17M-1.16
2024––-$56.79M-$51.32M-1.72
2023––-$69.64M-$64.73M-2.74
2022––-$42.26M-$42.78M-2.79
2021––-$21.57M-$28.06M-10.64